Trial
NCT00578292
Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Baylor College of Medicine
Collaborators
—
Condition
Thalassemia
Intervention
Busulfan
Why stopped
Stem cell transplant was determined SOC for this disease (study is not relevant)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-05-01